1. Introduction {#sec1}
===============

We present the case of acute-onset panhypopituitarism due to a rapid growing sellar metastasis of breast cancer, where adrenal crisis and manifest diabetes insipidus were triggered by a lower respiratory tract infection.

2. Case Presentation {#sec2}
====================

A 66-year-old woman presented to the emergency department with a two-day history of fever, cough, vomiting, and lethargy. Past medical history revealed a recently diagnosed recurrence of breast cancer with diffuse bone and mediastinal metastases. The patient was hypotensive (RR 85/55 mmHg, HR 105/min) and febrile (39.3°C). Arterial blood gas analysis showed global respiratory insufficiency. A chest computed tomography revealed an infiltrate in the left lower lobe. Fluid resuscitation and treatment with broad spectrum antibiotics were begun for presumed community-acquired pneumonia with septic shock. The patient was admitted to the ICU, where she required high doses of intravenous fluids and circulatory support with norepinephrine up to 0.4 ug/kgKG/min. Adjunct treatment with corticosteroids was started after obtaining a random cortisol of 258 nmol/L. The clinical condition of the patient stabilized rapidly, and norepinephrine was tapered within 8 hours after beginning of corticosteroid therapy. Confusingly, cosyntropin testing 14 hours later showed a basal cortisol of 136 nmol/L with an adequate absolute and relative (\>250 nM) increase of cortisol after 30 minutes to 579 nmol/L.

The presence of polyuria (600--800 ml/hr) despite septic shock raised the suspicion of diabetes insipidus, which was confirmed with a serum osmolality of 320 mosm/kg and a urine osmolality of 148 mosm/kg. Consequently, four ug of desmopressin was administered intravenously.

After 36 hours, corticosteroid infusion was stopped, as the formal requirements for adrenal insufficiency and critical-illness-related corticosteroid insufficiency \[[@B1], [@B2]\] were only marginally met. Furthermore, as only one dose of desmopressin had been given and polyuria had not developed again, desmopressin was paused as well. The patient was then discharged from the ICU.

The following day, the patient complained of nausea, vomiting, and polyuria again. Vital signs were stable, but due to the clinical presentation, adrenal crisis was postulated and methylprednisolone 40 mg intravenously every 8 hours was administered. Furthermore, the patient failed to concentrate urine with a urine osmolality of 146 mmol/l and hypernatremia of 151 mmol/l. Manifest central diabetes insipidus was diagnosed and desmopressin treatment was restarted.

The diagnosis of acute septic shock due to influenza A/H1N1-pneumonia was made retrospectively due to positive nasopharyngeal swabs.

Further exploration of pituitary axis testing confirmed panhypopituitarism with a low FSH level in a postmenopausal patient and low serum levels of TSH, free T4, growth hormone, and IGF-1. Also, posterior lobe pituitary insufficiency was confirmed with levels of vasopressin and copeptin \[[@B3]\] in the low-normal range at the presence of high urine output with a low urine osmolality and high serum sodium (for detailed laboratory values, see [Table 1](#tab1){ref-type="table"}).

Pituitary MRI showed signal increase suggesting hemorrhage in sagittal T1-weighted and coronal T2-weighted MRI, but coronal T1-weighted MRI with contrast showed inhomogeneous enhancement of pituitary with metastasis. The concluding diagnosis was a sellar metastasis ([Figure 1](#fig1){ref-type="fig"}) of the known metastasizing breast cancer. This lesion was new, as it had not been present in a PET scan 2 months earlier.

After 2 weeks, stimulated cortisol levels in the repeated low-dose cosyntropin test reached only 219 nmol/l.

3. Discussion {#sec3}
=============

Acute panhypopituitarism is rare and mostly due to acute ischemia or hemorrhage of the pituitary. In our patient, the reason for panhypopituitarism was a fast expanding sellar metastasis, with a pulmonary infection as a trigger for an adrenal crisis and manifest diabetes insipidus. The time course of the low-dose cosyntropin testing showed that it took two weeks for the adrenal glands to atrophy after loss of pituitary ACTH stimulation. Importantly, as exemplified in our patient, a misleading result of the cosyntropin testing in the initial phase with allegedly normal response to exogenous ACTH may be seen. The clinical presentation and suspicion in these patients are crucial together with the correct interpretation of an inadequately low random cortisol. Random serum cortisol and the response to cosyntropin test depend on the individual stress level \[[@B4], [@B5]\] and have to be interpreted with caution in critically ill patients with acute onset of a disease. Importantly, the critical care setting already represents a major stress stimulus for serum cortisol. Therefore, cosyntropin testing should not be routinely performed in the critical care setting \[[@B6], [@B7]\]. If adrenal failure in addition to septic shock or critical illness is suspected despite a borderline random cortisol, failure to stimulate after cosyntropin testing may help to diagnose primary adrenal insufficiency \[[@B8]\]. However, the present case shows that a high stimulated cortisol level does not rule out secondary adrenal insufficiency.
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###### 

Laboratory values.

  Variable                       Reference range, adults   One week before admission   Day 1, 10 a.m.   Day 1, 10 p.m.   Day 2   Day 3   Day 4   Day 8   Day 15   Day 32
  ------------------------------ ------------------------- --------------------------- ---------------- ---------------- ------- ------- ------- ------- -------- --------
  Hematocrit (%)                 36.0--45.0                0.423                       0.433            0.353            0.372   0.297                            0.384
  Hemoglobin (g/l)               120--155 g/l              140                         137              107              118     97                               118
  White cell count (per mm^3^)   4000--10000               5700                        9500             9400             6400    7000                             7390
  Thrombocytes (G/l)             140--400                  234                         287              277              292     243                              306
  Sodium (mmol/l)                136--146                  148                         139              153              147     147     151             143      144
  Potassium (mmol/l)             3.6--5.0                  3.6                         3.9                               3.8     4.3     4.2             4.3      4.3
  Osmolality (mosmol/kg)         280--300                                              298              320                              310             298       
  Urine osmolality (mosmol/kg)   100--1200                                                              148              274             146     271               
  Urea (mmol/l)                  2--7                                                  8.1                               4.6     4.9                     5.7      7
  Creatinine (umol/l)            53--94                    61                          170                               120     91      83              90       55
  Procalcitonin (ug/l)           \<0.5                     0.18                        0.47                              3.88                                      
  C-reactive protein mg/l        \<3.0                     15.8                        79.2                              71.3    100     47.3                      
  Copeptin (pmol/l)              \<31                                                  4.8                               2.3                                       
  Vasopressin (ADH) (pmol/l)     1.0--4.2                                                               \<0.90                                                     
  TSH (mU/l)                     0.4--4.0                                              0.14                              0.05            0.07    0.1               
  T3 (nmol/l)                    0.90--2.60                                                                              2.05            0.91                      
  fT4 (nmol/l)                   9.9--19.3                                                                                               10.1    8.71              
  HGH (ug/l)                     \<7                                                                                     0.23                                      
  IGF1 (ug/l)                    59--195                                                                                 64.7                                     105
  FSH (U/l)                      19--140                                                                                 1.08                                     1.77
  Prolactin (ug/l)               2.2--28                                                                                                 73.6                     94.3
  Morning cortisol (nmol/l)      140--700                                              258                                                                         
  Cosyntropin test (low dose)                                                                                                                                      
  Cortisol 0′ (nmol/l)                                                                                  136                                      292     122      67
  Cortisol 30′ (nmol/l)          \>500                                                                  579                                      497     356      219
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